Sarcomatoid renal cell carcinoma. A rare and aggressive variation of primary renal cell carcinoma;Das sarkomatoide nierenzellkarzinom. Eine seltene und aggressive variante des primären nierenzellkarzinoms

Urologe - Ausgabe A

Volumn 46, Issue 4, 2007, Pages 406-411

  Bannowsky, A ^a,b   Leuschner, I ^b   Schiller, H ^b   Bothe, K ^b   Osmonov, D ^b   Junemann K P ^b   Hautmann, S ^b  

^a Ev Luth Diakonissenanstalt zu Flensburg   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Histology; Prognosis; Renal cell carcinoma; Sarcomatoid

Indexed keywords

ALPHA INTERFERON; DOXORUBICIN; FLUOROURACIL; IFOSFAMIDE; INTERLEUKIN 2; VINBLASTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CARCINOSARCOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; KIDNEY CARCINOMA; NEPHRECTOMY; OUTCOME ASSESSMENT; RARE DISEASE; SURVIVAL;

ADULT; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RARE DISEASES; SARCOMA;

EID: 34247246181     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-006-1249-6     Document Type: Article

References (11)

1. Brinkmann OA, Hertle L (2001) Molekulargenetik des Nierenzellkarzinoms und Tumormarker. Onkologe 7: 715-721
2. Cangiano T, Liao J, Naitoh J et al. (1999) Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical re-section and immunotherapy. J Clin Oncol 17: 523-528
3. Cheville JC, Lohse CM, Zincke H et al. (2004)Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4): 435-441
4. Dall'Oglio MF, Lieberknecht M, Gouveia V et al. (2005) Sarcomatoid differentiation in renal cell carcinoma: Prognostic implications. Int Braz J Urol 31: 10-16
5. Farrow GM, Harrison EG Jr, Utz DC (1968) Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Cancer 22: 556-563
6. Nanus DM, Garino A, Milowsky MI et al. (2004) Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer 101(7): 1545-1551
7. Rashid MH, Welsh CT, Bissada NK, Chaudhary UB (2005) Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma. Am J Clin Oncol 28(1): 107-108
8. Riede UN (1995) Neoplastische Läsionen der Niere. In: Riede UN, Schaefer HE (Hrsg) Allgemeine und spezielle Pathologie. Thieme, Stuttgart New York, S 828-833
9. Ro JY, Ayala AG, Sella A et al. (1987) Sarcomatoid renal cell carcinoma: clinicopathological. A study of 42 cases. Cancer 59: 516-526
10. Selli C, Hinshaw WM, Woodard BH, Paulson DF (1983) Stratification of risk factors in renal cell carcinoma. Cancer 52: 899-903
11. Sella A, Logothetis CJ, Ro JY et al. (1987) Sarcomatoid renal cell carcinoma. A treatable entity. Cancer 60: 1313-1318